The Genomic Research and Accessibility Act - aiming to curb the gold rush on patenting human genes - is making its way through Congress. As of now, 20% of the human genome has been patented, which stymies research and gives individuals and corporations unprecedented power over humanity. You can do you part and show your support for Representatives Becerra's (D-CA) and Weldons' (R-FL) bill by sending a fax this week to the address below. More information on this issue can be found here.
The Honorable Xavier Becerra
United States House of Representatives
1119 Longworth House Office Building
Washington, D.C. 20515
fax 202.225.2202
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Aggregated News
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks.”
Bay Area-based R3 Bio has been quietly pitching the...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.